It turns out that humans, more than any other species, have a propensity for making chromosomally abnormal embryos. As women age, the chances are even higher that the embryos they create will not mature into live children. IGENOMIX, a global leader in the reproductive testing space with a vast presence in the US, Japan, India, Turkey, Rome, Brazil, Mexico, Canada, and Spain, tests thousands of embryos in its labs every month, in order to help couples select those that are most likely to be viable.
Keeping Our Resolve - When your New Year's resolutions include getting fit, spending more time outdoors, and reducing your carbon footprint, swapping bike for car as the way to work can be the perfect way to achieve all three.
When AstraZeneca wanted to update its pharmaceutical compound management with a fully acoustic system, we were happy to take on the challenge. Two years later, we are happy to be able to offer the amazing automated workflow solution to all of our customers, as part of the new Access™ Dual Robot System (DRS) - to be revealed at SLAS2018.
The future of precision oncology is happening now, in the labs of Seattle-based start-up SEngine, where individual patient tumor cells are screened against a library of nearly 150 drugs to find the optimal personalized treatment.
FIMM Extends Personalized Medicine Collaboration with Labcyte
It’s brought unparalleled levels of precision to precision medicine, and enabled cancer treatment to be truly tailored to individual patients. Now Labcyte’s acoustic liquid handling technology will help the Institute for Molecular Medicine Finland (FIMM) take its innovative functional cell screening strategies to the next level.